ICU Medical, Inc. (NASDAQ:ICUI) Shares Sold by Versor Investments LP

Versor Investments LP decreased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 26.8% during the 4th quarter, HoldingsChannel reports. The fund owned 5,207 shares of the medical instruments supplier’s stock after selling 1,911 shares during the quarter. Versor Investments LP’s holdings in ICU Medical were worth $808,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Creative Planning lifted its position in ICU Medical by 58.6% in the third quarter. Creative Planning now owns 6,193 shares of the medical instruments supplier’s stock valued at $1,128,000 after buying an additional 2,287 shares during the last quarter. Allworth Financial LP lifted its position in ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after buying an additional 100 shares during the last quarter. State of Alaska Department of Revenue lifted its position in ICU Medical by 16.0% in the third quarter. State of Alaska Department of Revenue now owns 13,938 shares of the medical instruments supplier’s stock valued at $2,539,000 after buying an additional 1,921 shares during the last quarter. Amalgamated Bank lifted its position in ICU Medical by 13.1% in the third quarter. Amalgamated Bank now owns 7,067 shares of the medical instruments supplier’s stock valued at $1,288,000 after buying an additional 816 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its position in ICU Medical by 24.6% in the third quarter. Principal Financial Group Inc. now owns 126,937 shares of the medical instruments supplier’s stock valued at $23,130,000 after buying an additional 25,031 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

ICU Medical Stock Down 2.3 %

ICUI stock opened at $146.33 on Friday. The company’s 50 day moving average price is $160.42 and its 200 day moving average price is $166.08. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. ICU Medical, Inc. has a fifty-two week low of $93.36 and a fifty-two week high of $196.26. The firm has a market capitalization of $3.58 billion, a price-to-earnings ratio of -32.02 and a beta of 0.63.

Insider Buying and Selling at ICU Medical

In other news, CEO Vivek Jain sold 12,000 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $162.91, for a total value of $1,954,920.00. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $17,039,245.63. This represents a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 6.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have commented on ICUI shares. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday, December 11th. Needham & Company LLC reiterated a “hold” rating on shares of ICU Medical in a research note on Wednesday, November 13th. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Wednesday, November 20th. Finally, KeyCorp boosted their price target on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $199.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.